Skip to content
Home/Companies/Biotech/Poxel
Poxel

Poxel

Biotech·France·Active·16yr hold
Entry
2010
Hold
16yr
Status
Active

Who owns Poxel?

Poxel is a French Biotech company, currently owned by Andera Partners since 2010.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.poxelpharma.com

More from BioDiscovery 3

Other portfolio companies in the same fund.

Cellnovo
Exited 2015
MedTechFrance· 2011
GenKyoTex
Exited 2014
BiotechFrance· 2011
Sapiens
Sapiens
Exited 2013
SaaSFrance· 2011
to Medtronic
Covagen
Exited 2014
BiotechFrance· 2010
to Johnson & Johnson
Parvulus Medical
Exited
MedTechFrance· 2010
Endosense
Exited 2013
MedTechFrance· 2009
to St. Jude Medical

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Poxel?

Poxel is currently owned by Andera Partners, through BioDiscovery 3, since 2010.

When did Andera Partners acquire Poxel?

Andera Partners acquired Poxel in 2010.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue